Location History:
- Laporte, CO (US) (2000)
- Fort Collins, CO (US) (2000 - 2001)
Company Filing History:
Years Active: 2000-2001
Introduction
Robert E. Wagner, Jr. is a distinguished inventor based in Fort Collins, Colorado, known for his significant contributions to the field of genetic mutation detection. With a total of three patents to his name, Wagner's work is primarily focused on advancing methods for identifying mutations in biological samples, which have critical implications for diagnosing genetic diseases.
Latest Patents
One of Wagner's notable patents involves methods for detecting triplet repeat blocks and a functional mismatch binding protein in a biological fluid sample. This innovative approach enables the detection of mutations, such as single base changes or small insertions and deletions in DNA sequences. Utilizing an immobilized DNA mismatch-binding protein like MutS, this method facilitates the identification of mutations that could lead to serious health issues, including mutated oncogenes and genetic disorders such as fragile X syndrome. Additionally, Wagner's methods enhance the isolation of error-containing molecules in DNA samples, showcasing his commitment to improving genetic diagnostics.
Another key patent by Wagner is the method for using an immobilized mismatch-binding protein for detecting mutations. Like his previous innovation, this method emphasizes the detection of small mutations, providing essential tools for diagnosing diseases linked to genetic mutations. The techniques developed by Wagner are vital for applications in clinical settings, offering new ways to address complex genetic conditions.
Career Highlights
Throughout his career, Robert E. Wagner, Jr. has worked with prominent companies, such as Valigene Corporation and Valigen, Inc. These experiences have not only provided him with valuable insights into the applications of his inventions but also facilitated collaboration with other leading experts in the field.
Collaborations
Wagner's partnerships with Valigene Corporation and Valigen, Inc. reflect his dedication to leveraging scientific advancements in genetics. These collaborations have likely contributed to the development and refinement of his innovative methods in detecting genetic mutations, delivering significant impact within the medical community.
Conclusion
Robert E. Wagner, Jr. exemplifies the spirit of innovation through his focused research on genetic mutation detection. His patents not only enhance the ability to diagnose important genetic conditions but also pave the way for advancements in medical genetics. As he continues to develop new methods and products, Wagner’s contributions will undoubtedly leave a lasting impact on the field of genetic diagnostics.